203 related articles for article (PubMed ID: 35794505)
41. Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis.
Dong T; Liu Z; Xuan Q; Wang Z; Ma W; Zhang Q
Sci Rep; 2017 Jul; 7(1):6069. PubMed ID: 28729678
[TBL] [Abstract][Full Text] [Related]
42. Clinical Significance and Prognostic Value of Lactate Dehydrogenase Expression in Cervical Cancer.
Ye Y; Chen M; Chen X; Xiao J; Liao L; Lin F
Genet Test Mol Biomarkers; 2022 Mar; 26(3):107-117. PubMed ID: 35349377
[No Abstract] [Full Text] [Related]
43. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
Fu Y; Lan T; Cai H; Lu A; Yu W
Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
[TBL] [Abstract][Full Text] [Related]
44. Combining
Lin X; Xiao Z; Hu Y; Zhang X; Fan W
Front Pharmacol; 2020; 11():592768. PubMed ID: 33192532
[No Abstract] [Full Text] [Related]
45. Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients.
Brown JE; Cook RJ; Lipton A; Coleman RE
Clin Cancer Res; 2012 Nov; 18(22):6348-55. PubMed ID: 22952345
[TBL] [Abstract][Full Text] [Related]
46. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma.
Wei XL; Zhang DS; He MM; Jin Y; Wang DS; Zhou YX; Bai L; Li ZZ; Luo HY; Wang FH; Xu RH
Tumour Biol; 2016 Feb; 37(2):1879-87. PubMed ID: 26323257
[TBL] [Abstract][Full Text] [Related]
47. Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis.
Petrelli F; Ardito R; Merelli B; Lonati V; Cabiddu M; Seghezzi S; Barni S; Ghidini A
Melanoma Res; 2019 Feb; 29(1):1-12. PubMed ID: 30308577
[TBL] [Abstract][Full Text] [Related]
48. Prognostic Role of Lactate Dehydrogenase Expression in Urologic Cancers: A Systematic Review and Meta-Analysis.
Zhang Y; Xu T; Wang Y; Zhang H; Zhao Y; Yang X; Cao Y; Yang W; Niu H
Oncol Res Treat; 2016; 39(10):592-604. PubMed ID: 27710971
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.
Zhang J; Yao YH; Li BG; Yang Q; Zhang PY; Wang HT
Sci Rep; 2015 Apr; 5():9800. PubMed ID: 25902419
[TBL] [Abstract][Full Text] [Related]
50. The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.
Lisanti C; Basile D; Parnofiello A; Bertoli E; Andreotti VJ; Garattini SK; Bartoletti M; Cattaneo M; Di Nardo P; Bonotto M; Casagrande M; Da Ros L; Cinausero M; Foltran L; Pella N; Buonadonna A; Aprile G; Fasola G; Puglisi F
J Geriatr Oncol; 2020 Nov; 11(8):1268-1273. PubMed ID: 32576519
[TBL] [Abstract][Full Text] [Related]
51. Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer.
Huang W; Liu P; Zong M; Chen QQ; Zhou H; Kong H; Xie WP
Cancer Manag Res; 2021; 13():4299-4307. PubMed ID: 34103985
[TBL] [Abstract][Full Text] [Related]
52. [Prognostic Value of Corrected Levels of Serum Calcium and Serum Lactate Dehydrogenase for Newly Diagnosed Multiple Myeloma Patients].
Xie YM; Cui YJ; Li H; Pan XR; Xu YX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):844-849. PubMed ID: 31204942
[TBL] [Abstract][Full Text] [Related]
53. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
[TBL] [Abstract][Full Text] [Related]
54. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma.
Li G; Gao J; Tao YL; Xu BQ; Tu ZW; Liu ZG; Zeng MS; Xia YF
Chin J Cancer; 2012 Apr; 31(4):197-206. PubMed ID: 22237040
[TBL] [Abstract][Full Text] [Related]
55. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival.
Ma L; Qiu J; Zhang Y; Qiu T; Wang B; Chen W; Li X; Sun J; Wang K; Li X; Gu Y; Shu Y; Chen X
Onco Targets Ther; 2018; 11():2533-2543. PubMed ID: 29765232
[TBL] [Abstract][Full Text] [Related]
58. Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score.
Berghoff AS; Wolpert F; Holland-Letz T; Koller R; Widhalm G; Gatterbauer B; Dieckmann K; Birner P; Bartsch R; Zielinski CC; Weller M; Preusser M
Neuro Oncol; 2017 Sep; 19(9):1255-1262. PubMed ID: 28096493
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.
Zhang M; Wei S; Su L; Lv W; Hong J
Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859
[TBL] [Abstract][Full Text] [Related]
60. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer.
Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y
Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
